Abstract
Breast Cancer Type 1 Susceptibility Protein (BRCA)-1 existing in several functionally distinct complexes, promotes DNA repair of DNA double-strand breaks (DSBs). A recent study by Tang and colleagues identifies the lysine methyltransferase Disruptor of Telomeric Silencing 1-Like (DOT1L) involved in modifying Receptor-Associated Protein 80 (RAP80) to promote BRCA1-A complex localization and repair functions at DNA breaks. This study illuminates a potential therapeutic target for cancer radiotherapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 955-957 |
| Number of pages | 3 |
| Journal | Trends in Pharmacological Sciences |
| Volume | 45 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2024 |
Keywords
- BRCA1
- DOT1L
- RAP80
- homologous recombination
- radiotherapy
ASJC Scopus subject areas
- Toxicology
- Pharmacology